Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Bente Juel Riis"'
Autor:
Asger Reinstrup Bihlet, Inger Byrjalsen, Jeppe Ragnar Andersen, Simone Faurholt Simonsen, Kamilla Mundbjerg, Betina Helmer, Bente Juel Riis, Morten Asser Karsdal, Claus Christiansen
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Menopause is associated with detrimental changes in turnover of bone and cartilage and a variety of symptoms with negative impact on the quality of life. Naturally occurring isoflavones from Radix Pueraria lobata, Kudzu root, may possess
Externí odkaz:
https://doaj.org/article/fe2b4aa4d4d844318a655c0fe7a44ea6
Autor:
Asger Reinstrup Bihlet, Inger Byrjalsen, Anne-Christine Bay-Jensen, Jeppe Ragnar Andersen, Claus Christiansen, Bente Juel Riis, Morten A. Karsdal
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Abstract Background Excessive cartilage degradation is a known characteristic of osteoarthritis (OA). Biochemical markers, such as uCTX-II, have been shown to be associated with disease severity, yet the tissue origin of CTX-II has been disputed. Thi
Externí odkaz:
https://doaj.org/article/b0b4a66efd5a435386b7e6a1053b1c89
Autor:
Asger Reinstrup Bihlet, Inger Byrjalsen, Anne-Christine Bay-Jensen, Jeppe Ragnar Andersen, Claus Christiansen, Bente Juel Riis, Ivo Valter, Morten A. Karsdal, Marc C. Hochberg
Publikováno v:
BMC Musculoskeletal Disorders, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Pain is the principal clinical symptom of osteoarthritis (OA), and development of safe and effective analgesics for OA pain is needed. Drug development of new analgesics for OA pain is impaired by substantial change in pain in pat
Externí odkaz:
https://doaj.org/article/aaa04b30ab1b4610b042db1c2904669f
Autor:
Martin Michealis, Christoph Ladel, Asger Reinstrup Bihlet, Anne-Christine Bay-Jensen, Jeppe Ragnar Andersen, Bente Juel Riis, Claus Christiansen, Hans Guehring, Inger Byrjalsen, Morten A. Karsdal
BackgroundThe heterogeneous nature of osteoarthritis (OA) and the need to subtype patients is widely accepted. The biomarker CRPM, a metabolite of C-reactive protein (CRP), is released to the circulation during inflammation. Blood CRPM levels have sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2ff15e93cb34b72c28bb1cd30b57f13
https://doi.org/10.21203/rs.3.rs-41634/v1
https://doi.org/10.21203/rs.3.rs-41634/v1
Autor:
Henning B. Nielsen, Marie S. Worm, Joseph P.M. Blair, Bente Juel Riis, Cecilie L. Bager, Niels H. Secher, Claus Christiansen
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Worm, M S, Bager, C L, Blair, J P M, Secher, N H, Riis, B J, Christiansen, C & Nielsen, H B 2020, ' Atrial fibrillation is associated with lean body mass in postmenopausal women ', Scientific Reports, vol. 10, no. 1, 573 . https://doi.org/10.1038/s41598-019-57167-3
Scientific Reports
Worm, M S, Bager, C L, Blair, J P M, Secher, N H, Riis, B J, Christiansen, C & Nielsen, H B 2020, ' Atrial fibrillation is associated with lean body mass in postmenopausal women ', Scientific Reports, vol. 10, no. 1, 573 . https://doi.org/10.1038/s41598-019-57167-3
Scientific Reports
This study investigated the association between body composition and risk of atrial fibrillation (AF) in postmenopausal women. In a retrospective analysis we assessed data from 5704 postmenopausal women (age 70.7 ± 6.5 yrs.) who in 1999–2001 parti
Autor:
John P. Bilezikian, Ming-yi Hu, Lorraine A. Fitzpatrick, Claus Christiansen, Bente Juel Riis, Felicia Cosman, Gregory C. Williams, Paul D. Miller, Gary Hattersley, Dennis M. Black, Ivo Valter
Publikováno v:
Mayo Clinic Proceedings. 92:200-210
Objective To assess the efficacy and safety of 18 months of subcutaneous abaloparatide (ABL-SC) or placebo (PBO) followed by 6 months of alendronate (ALN) (preplanned interim analysis). Patients and Methods ACTIVExtend, an extension of ACTIVE, enroll
Autor:
Anne-Christine Bay-Jensen, J.J. Bjerre-Bastos, Jeppe Ragnar Andersen, Bente Juel Riis, Asger Reinstrup Bihlet, Claus Christiansen, Inger Byrjalsen, Morten A. Karsdal
Publikováno v:
Poster Presentations.
Background Osteoarthritis (OA) can lead to joint failure and ultimately total joint replacement (TJR). Identifying risk-factors of developing joint failure is of interest for clinicians and researchers. Currently late-stage clinical trial design for
Autor:
Inger Byrjalsen, Morten A. Karsdal, Jeppe Ragnar Andersen, Bente Juel Riis, Claus Christiansen, Asger Reinstrup Bihlet, Anne-Christine Bay-Jensen
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Background Excessive cartilage degradation is a known characteristic of osteoarthritis (OA). Biochemical markers, such as uCTX-II, have been shown to be associated with disease severity, yet the tissue origin of CTX-II has been disputed. This analysi
Publikováno v:
Respiratory medicine. 153
Autor:
Edith M. C. Lau, Paul D. Miller, Lorraine A. Fitzpatrick, Ming-yi Hu, Gregory C. Williams, Luis A. Russo, Bente Juel Riis, C. Christiansen, Gary Hattersley, Alan G. Harris
Publikováno v:
Bone. 120
Abaloparatide is a 34-amino acid peptide that selectively binds to the RG conformation of the parathyroid hormone receptor type 1. It was developed for the treatment of women with postmenopausal osteoporosis at high risk of fracture. In ACTIVE, an 18